A study to screen the presence of Prameha Purvaroopa (Pre-Clinical features) in newly diagnosed Type 2 Diabetes Mellitus patients .

Not Applicable

Conditions: Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Registration Number: CTRI/2019/10/021799

Lead Sponsor: State Ayurvedic College And Hospital Lucknow

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1.Any one of either gender between 30 to 60 years diagnosed recently (within one year from the date of recruitment ) for having diabetes mellitus.( to be confirmed by observation of previous investigation followed by a new blood sugar investigation at the time of recruitment )

2. Patient who are fulfilling the criteria one and not having any cognitive impairment making a retrospective recall, difficult.

3. Patient fulfilling the inclusion criteria one and two and are willing to participate in the proposed observational study.

Exclusion Criteria

1.Patient not complying to any of the criteria as are specified in inclusion category.

2.Those subjects who have co-existences illness beside diabetes and which may interfere in the symptoms presentation will be excluded from the study ex. UTI, Neuropathy , Hyperthyroidism ,Hypothyroidism , vitamin B Complex deficiency etc.

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary end point -1.Establishment of presence ofprameh specific purvaroopa,in newly diagnosed diabetic population upon their retrospective screening . <br/ ><br>Secondary end point -1.To establish those purvaroopa which appear earliest in the process of pathogenesis this will help us understanding the earliest warning sign for upcoming prameh. <br/ ><br>2- To establish the heterogeneousity of diabetic population on the basis of differential presence of purvaroopa in the diabetic population. <br/ ><br>Timepoint: 1 year

Secondary Outcome Measures

Name	Time	Method
Secondary end point -1.To establish those purvaroopa which appear earliest in the process of pathogenesis this will help us understanding the earliest warning sign for upcoming prameh. <br/ ><br>2- To establish the heterogeneousity of diabetic population on the basis of differential presence of purvaroopa in the diabetic population. <br/ ><br>Timepoint: 1 year